Biotechnology has entered an era where scientific capability is expanding faster than any individual organization can fully exploit.
That changes how companies should think about strategy.
The future will not belong exclusively to the largest organizations or the smallest startups.
It will belong to companies that consistently integrate discovery science, artificial intelligence, strategic partnerships, platform technologies, manufacturing, regulatory expertise, and commer
